Respiratory Infections News

Primary care patients with a low lymphocyte count “years before” developing pneumonia were at an increased risk for dying, researchers of a retrospective cohort study wrote in the British Journal of General Practice.

Moderna said it has modified its COVID-19 vaccine to target the B.1.351 variant and shipped doses to the NIH for phase 1 testing.

A study involving more than 1,000 patients identified cardiac involvement, age and race as attributes that could differentiate multisystem inflammatory syndrome in children from severe COVID-19, researchers reported in JAMA.

The FDA reviewed data on Johnson & Johnson’s one-shot COVID-19 vaccine and found no issues that would prevent its emergency use authorization, according to a briefing document meant for the expert panel that will review the vaccine this week.

Patients with COVID-19 antibodies appear to be protected against reinfection for at least a few months, according to research published JAMA Internal Medicine.

Pharmaceutical executives from Pfizer, Moderna, Johnson & Johnson, AstraZeneca and Novavax testified Tuesday that they are on track to deliver a combined 1.1 billion doses of COVID-19 vaccine in the United States by the end of July.

The Infectious Diseases Society of America has backed the use of tocilizumab for COVID-19.

According to the CDC, influenza activity this season has been “unusually low,” with rates of hospitalization as of late January that were similar to 2011-2012 — the least severe season in the past decade.

I know people in this field often say that they wanted to work in infectious diseases ever since they were an embryo or a small child. But that was really the case with me.

Educators were “central” to in-school transmission of SARS-CoV-2 in one Georgia school district during a recent 7-week period, investigators reported in MMWR.